Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653) These data provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results